Pain Market Research Reports & Industry Analysis
In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.
The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.
Pain Industry Research & Market Reports
-
2022 Global Forecast for Veterinary Pain Management (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
Leading Intrathecal Pumps Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $59.2 Million in 2020, and is anticipated to reach $177.4 Million by 2029, registering a CAGR of 13.02%. Asia-Pacific and North America ... Read More
-
Insomnia Market By Therapy Type (Non pharmacological Therapy, Pharmacological Therapy): Global Opportunity Analysis and Industry Forecast, 2020-2030
... 6,315.9 million by 2030, registering a CAGR of 3.9% from 2021 to 2030. Insomnia is a sleep disorder wherein people find it difficult to sleep or remain asleep. The symptoms for insomnia include, low stamina, ... Read More
-
Leading Minor Cannabinoids Country Markets Databank
... 2029. Asia-Pacific is expected to be the highest contributor to this market, with $2,718.5 Million in 2020, and is anticipated to reach $5,888.3 Million by 2029, registering a CAGR of 9.01%. Asia-Pacific and North America ... Read More
-
Europe Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
North America Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Asia-Pacific Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
North America Minor Cannabinoids Market Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
-
Global Intrathecal Pumps Market Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Leading Intrathecal Pumps Type Markets Databank
... 2029. Baclofen segment is expected to be the highest contributor to this market, with $65.3 Million in 2020, and is anticipated to reach $181.1 Million by 2029, registering a CAGR of 12.05%. Baclofen and Bupivacaine ... Read More
-
Cannabidiol (CBD) Market Size By Product (Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On, CBD Inhalers), By Application (Anxiety/Stress, Sleep/Insomnia, Chronic Pain, Migraine, Skin Care, Seizures, Joint Pain & Inflammation, Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, ... Read More
-
Global Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
Leading Minor Cannabinoids Product Markets Databank
... 2029. Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid ... Read More
-
Leading Minor Cannabinoids Application Markets Databank
... 2029. Cancer segment is expected to be the highest contributor to this market, with $1,514.2 Million in 2020, and is anticipated to reach $2,883.6 Million by 2029, registering a CAGR of 7.47%. Pain Management segment ... Read More
-
Latin America, Middle East & Africa Intrathecal Pumps Market Databank
... 11.87% from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of ... Read More
-
Leading Intrathecal Pumps Application Markets Databank
... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More
-
Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape. Cluster headache is pain that occurs along ... Read More
-
Post-Operative Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Pain is one of the main postoperative adverse outcomes causing distress to ... Read More
-
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Complex Regional Pain Syndrome - Drugs in Development by Stages, Target, MoA, RoA, Mol, provides an overview of the Complex Regional Pain Syndrome (Central Nervous System) pipeline landscape. Complex regional pain syndrome (CRPS) is a ... Read More
-
Veterinary Pain Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... million by 2027 at a CAGR of 6.61% during the forecast period, 2022-2027. The global outbreak of COVID-19 has impacted all industries including veterinary pain medicine. Pet parents are advised to keep a safe distance ... Read More
-
Pain Management Devices Market (Product Type: Electrical Stimulation Devices [Transcutaneous Electrical Nerve Stimulation {TENS} Devices, Neuromuscular Electrical Stimulation {NMES/EMS} Devices, and Other Electrical Stimulation Devices], Radiofrequency Ablation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], and Neurostimulation Devices [Spinal Cord Stimulation {SCS} Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, and Sacral Nerve Stimulation Devices; and Application: Electrical Stimulation Devices, Neurostimulation Devices, Analgesic Infusion Pump, and Radiofrequency Ablation Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... External Infusion Pumps], and Neurostimulation Devices [Spinal Cord Stimulation {SCS} Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, and Sacral Nerve Stimulation Devices; and Application: Electrical Stimulation Devices, Neurostimulation Devices, Analgesic Infusion Pump, and ... Read More
-
Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson’s Disease, OUD, Alzheimer’s Disease, AUD, TUD, Eating Disorder, and Narcolepsy) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... Scope of the Report The report provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the ... Read More
-
Global Cryotherapy Market Size study, By Product (Cryosurgery Devices, Localized Cryotherapy Devices, Cryochambers & Cryosaunas), By Application (Surgical Applications, Pain Management, Recovery, Health, and Beauty), By End User (Hospitals & Specialty Clinics, Cryotherapy Centers, Spas & Fitness Centers), and Regional Forecasts 2022-2028
... & Fitness Centers), and Regional Forecasts 2022-2028 Global Cryotherapy Market is valued approximately USD 224.75 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.1% over the forecast ... Read More
-
Dysmenorrhea Treatment Market—Forecast till 2027
... million by 2027. It is a commonly found disease in women during their menstrual cycle. The changing life and diet impacted the menstrual cycle among ladies. High work pressure, tension deferred the feminine cycle and ... Read More
Research Assistance
